XML 18 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Jun. 30, 2024
Current assets:    
Cash and cash equivalents $ 62,584 $ 68,570
Restricted cash 1,433 485
Accounts receivable, net of allowance for credit losses of $821 and $2,251 as of December 31, 2024, and June 30, 2024, respectively [1] 87,275 92,001
Inventories, net 148,826 138,324
Prepaid expenses and other current assets [2] 25,440 23,006
Deferred cost of revenue 333 850
Total current assets 325,891 323,236
Property and equipment, net 26,881 24,774
Investment in joint venture 12,837 9,826
Operating lease right-of-use assets, net 31,716 33,773
Goodwill 57,643 57,672
Restricted cash 1,371 1,337
Other assets 22,043 18,009
Total assets 478,382 468,627
Current liabilities:    
Accounts payable 53,991 50,020
Accrued compensation 19,350 17,128
Operating lease liabilities, current 7,518 6,218
Other accrued liabilities 27,987 28,508
Customer advances 12,959 13,988
Deferred revenue 72,088 71,649
Short-term debt 7,560 7,756
Total current liabilities 201,453 195,267
Long-term liabilities:    
Operating lease liabilities, non-current 30,459 32,373
Long-term other liabilities 6,010 7,389
Deferred revenue, non-current 24,616 24,114
Long-term debt 167,953 164,400
Total liabilities 430,491 423,543
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, $0.001 par value; authorized: 200,000,000 shares as of December 31, 2024, and June 30, 2024, respectively; issued and outstanding: 102,808,518 and 100,194,932 shares at December 31, 2024, and June 30, 2024, respectively 103 100
Additional paid-in-capital 572,287 566,887
Accumulated other comprehensive loss (5,401) (4,222)
Accumulated deficit (519,098) (517,681)
Total stockholders' equity 47,891 45,084
Total liabilities and stockholders' equity $ 478,382 $ 468,627
[1] Includes accounts receivable from the joint venture, an equity method investment, of $26,082 and $25,339 at December 31, 2024, and June 30, 2024, respectively. See Note 12.
[2] Includes other receivables from the joint venture, an equity method investment, of $377 and $743 at December 31, 2024, and June 30, 2024, respectively.